Mairi McClean

Dec 10, 2024 | publications.ersnet.org | Traian Constantin Panciu |Christoph Lange |Raquel Duarte |Mairi McClean

IntroductionTuberculosis (TB) is a persistent global health challenge, with 7.5 million new diagnoses and an estimated incidence of 10.6 million cases in 2022 [1]. At present, achieving the World Health Organization (WHO) End-TB Strategy's ambitious aims for a 95% decrease in TB-related deaths and a 90% decline in TB incidence rate by 2035 appears unrealistic [2]. The status quo of TB control methods is fraught with challenges.